A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/137 (2006.01) A61K 31/16 (2006.01) A61K 31/165 (2006.01) A61K 31/167 (2006.01) A61K 31/27 (2006.01) A61K 31/41 (2006.01) A61K 31/4196 (2006.01) A61K 31/47 (2006.01) A61P 3/06 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2554982
The present invention aims to provide for the treatment of hyperlipidemia, arteriosclerosis and hyper-remnant-emia, and to inhibit remnant lipoportein production by adminsetering an inhibitor of CEPT (cholesteryl ester transfer protein). Said inhibitor is a compound selected from the group cosisting of compounds of formula I to fomula XXIII, and compounds selected from the group consisting of JTT-705, CP-529414, SC-795, SC-744, SC-554, SC-71952, SC-56960, SC-57201, PD-140195, WK-5341A, WK-5344B, CETI-1 (CETP Vaccine), BM99-1 and BM99-2.
L'objectif de la présente invention est de fournir un procédé pour inhiber la production de lipoprotéines restantes et un inhibiteur de production de lipoprotéines restantes, lequel procédé consiste à administrer un composé possédant une activité inhibitrice de la CETP à un sujet. L'inhibiteur de production de lipoprotéines restantes selon la présente invention contient comme principe actif un composé possédant une activité inhibitrice de la CETP.
Furukawa Noboru
Okamoto Hiroshi
Sasase Tomohiko
Japan Tobacco Inc.
Ridout & Maybee Llp
LandOfFree
Method of inhibiting remnant lipoprotein production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting remnant lipoprotein production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting remnant lipoprotein production will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1440471